The Value of Inflammatory Biomarkers in Differentiating Asthma–COPD Overlap from COPD

References

• Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease, Diagnosis of Disease of Chronic Airflow Limitation. Asthma, COPD, and asthma–COPD overlap syndrome (ACOS); 2015 Available from: http://www.ginasthma.org/. Accessed 114, 2020.
   Google Scholar
• BarrechegurenM, EsquinasC, MiravitllesM. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74–79. doi:10.1097/mcp.000000000000011825405671
   PubMed Web of Science ®Google Scholar
• MiravitllesM, SorianoJB, AncocheaJ, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.00723597591
   PubMed Web of Science ®Google Scholar
• ZekiAA, SchivoM, ChanA, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo). 2011;2011:861926. doi:10.1155/2011/86192622121384
   PubMedGoogle Scholar
• Global strategy for the diagnosis management, and prevention of chronic obstructive pulmonary disease; 2020 Available from:https://goldcopd.org/. Accessed 114, 2020.
   Google Scholar
• ArnoldRJ, MassanariM, LeeTA, et al. A review of the utility and cost effectiveness of monitoring fractional exhaled nitric oxide (FeNO) in asthma management. Manag Care. 2018;27:34–41.
   PubMedGoogle Scholar
• PetskyHL, KewKM, TurnerC, et al. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016;9:Cd011440. doi:10.1002/14651858.CD011440.pub227580628
   PubMed Web of Science ®Google Scholar
• PetskyHL, LiA, ChangAB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2017;8:Cd005603. doi:10.1002/14651858.CD005603.pub328837221
   PubMed Web of Science ®Google Scholar
• SiddiquiSH, GuasconiA, VestboJ, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–525. doi:10.1164/rccm.201502-0235LE26051430
   PubMed Web of Science ®Google Scholar
• Vedel-KroghS, NielsenSF, LangeP, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. the copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–974. doi:10.1164/rccm.201509-1869OC26641631
   PubMed Web of Science ®Google Scholar
• KerkhofM, SonnappaS, PostmaDS, et al. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017;50. doi:10.1183/13993003.00761-2017
   Web of Science ®Google Scholar
• FurutateR, IshiiT, MotegiT, et al. The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease. Intern Med. 2016;55(3):223–229. doi:10.2169/internalmedicine.55.577226831014
   PubMed Web of Science ®Google Scholar
• PlazaV, AlvarezF, CalleM, et al. Consensus on the asthma-COPD overlap syndrome (ACOS) between the Spanish COPD guidelines (GesEPOC) and the Spanish guidelines on the management of asthma (GEMA). Arch Bronconeumol. 2017;53(8):443–449. doi:10.1016/j.arbres.2017.04.00228495077
   PubMed Web of Science ®Google Scholar
• Pilaczynska-CemelM, GoldaR, DabrowskaA, et al. Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/ lymphocyte, CRP/CIC) in patients with obstructive diseases. Cent Eur J Immunol. 2019;44(3):292–298. doi:10.5114/ceji.2019.8749831871418
   PubMed Web of Science ®Google Scholar
• KobayashiS, HanagamaM, YamandaS, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2117–2123. doi:10.2147/copd.S11364727660429
   PubMed Web of Science ®Google Scholar
• ChenFJ, HuangXY, LiuYL, et al. Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2385–2390. doi:10.2147/copd.S11537827713629
   PubMed Web of Science ®Google Scholar
• GuoY, HongC, LiuY, et al. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome. Medicine (Baltimore). 2018;97(23):e10857. doi:10.1097/md.000000000001085729879019
   PubMed Web of Science ®Google Scholar
• TakayamaY, OhnishiH, OgasawaraF, et al. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018;13:2525–2532. doi:10.2147/copd.S16760030174422
   PubMed Web of Science ®Google Scholar
• DengDD, ZhouAY, ShuangQC, et al. The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome. Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:98–101. doi:10.3760/cma.j.issn.1001-0939.2017.02.00428209039
   PubMedGoogle Scholar
• GotoT, CamargoCA Jr, HasegawaK. Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the national health and nutrition examination survey, 2007–2012. Int J Chron Obstruct Pulmon Dis. 2016;11:2149–2155. doi:10.2147/copd.S11087927660432
   PubMed Web of Science ®Google Scholar
• GaoSJ, GeYP, ZhangCJ. Correlation between fractional exhaled nitric oxide levels and efficacy of inhaled corticosteroids in children with bronchial asthma. Am J Ther. 2018;25(6):e617–e625. doi:10.1097/mjt.000000000000042326990963
   PubMed Web of Science ®Google Scholar
• DemarcheSF, SchleichFN, HenketMA, et al. Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre. BMJ Open. 2017;7(11):e018186. doi:10.1136/bmjopen-2017-018186
   PubMed Web of Science ®Google Scholar
• RouhosA, EkroosH, KarjalainenJ, et al. Smoking attenuates increase in exhaled nitric oxide in atopic but not in nonatopic young adults with asthma. Int Arch Allergy Immunol. 2010;152(3):226–232. doi:10.1159/00028302920150740
   PubMed Web of Science ®Google Scholar
• ChalmersGW, MacLeodKJ, ThomsonL, et al. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120(6):1917–1922. doi:10.1378/chest.120.6.191711742922
   PubMed Web of Science ®Google Scholar
• ATS/ERS. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930. doi:10.1164/rccm.200406-710ST.15817806
   PubMed Web of Science ®Google Scholar
• PapaiwannouA, ZarogoulidisP, PorpodisK, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6(Suppl 1):S146–151. doi:10.3978/j.issn.2072-1439.2014.03.0424672688
   PubMed Web of Science ®Google Scholar
• Toledo-PonsN, van BovenJFM, Roman-RodriguezM, et al. ACO: time to move from the description of different phenotypes to the treatable traits. PLoS One. 2019;14(1):e0210915. doi:10.1371/journal.pone.021091530677059
   PubMed Web of Science ®Google Scholar
• MiravitllesM, Soler-CataluñaJJ, CalleM, et al. Spanish guideline for COPD (GesEPOC). Arch Bronconeumol. 2014;50(Suppl 1):1–16. doi:10.1016/s0300-2896(14)70070-5
   PubMed Web of Science ®Google Scholar
• JacintoT, MalinovschiA, JansonC, et al. Differential effect of cigarette smoke exposure on exhaled nitric oxide and blood eosinophils in healthy and asthmatic individuals. J Breath Res. 2017;11(3):036006. doi:10.1088/1752-7163/aa746b28825404
   PubMed Web of Science ®Google Scholar
• Al-SawalhaNA, MigdadiAM, AlzoubiKH, et al. Effect of waterpipe tobacco smoking on airway inflammation in murine model of asthma. Inhal Toxicol. 2017;29(2):46–52. doi:10.1080/08958378.2017.128010528330430
   PubMed Web of Science ®Google Scholar
• ShimodaT, ObaseY, KishikawaR, et al. Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma. Allergy Asthma Proc. 2016;37(4):50–58. doi:10.2500/aap.2016.37.3944
   PubMed Web of Science ®Google Scholar
• AlshabanatA, ZafariZ, AlbanyanO, et al. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.013606526336076
   PubMed Web of Science ®Google Scholar
• AndersenH, LampelaP, NevanlinnaA, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342–346. doi:10.1111/crj.1201323362945
   PubMed Web of Science ®Google Scholar
• KurashimaK, TakakuY, OhtaC, et al. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:479–487. doi:10.2147/copd.S9734327019598
   PubMed Web of Science ®Google Scholar
• SorinoC, PedoneC, ScichiloneN. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med. 2016;34:72–77. doi:10.1016/j.ejim.2016.06.02027357368
   PubMed Web of Science ®Google Scholar
• WangW, HuangKW, WuBM, et al. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma. Chin Med J (Engl). 2012;125:3157–3160.22932198
   PubMed Web of Science ®Google Scholar
• GaoJ, WuF. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy Asthma Clin Immunol. 2018;14:21. doi:10.1186/s13223-018-0248-729796021
   PubMed Web of Science ®Google Scholar
• AlvingK, MalinovschiA. Basic aspects of exhaled nitric oxide. Eur Respir Monogr. 2011;49:1–31.
   Google Scholar
• StirlingRG, van RensenEL, BarnesPJ, et al. Interleukin-5 induces CD34+ eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001;164(8):1403–1409. doi:10.1164/ajrccm.164.8.201000211704586
   PubMed Web of Science ®Google Scholar
• PradoCM, Leick-MaldonadoEA, ArataV, et al. Neurokinins and inflammatory cell iNOS expression in guinea pigs with chronic allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol. 2005;288(4):L741–748. doi:10.1152/ajplung.00208.200415579630
   PubMed Web of Science ®Google Scholar
• HartjesFJ, VonkJM, FaizA, et al. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Respirology. 2018;23(11):1023–1031. doi:10.1111/resp.1331229696728
   PubMed Web of Science ®Google Scholar
• ShiF, QiuC, YuJ, et al. Comparison of fractional exhaled nitric oxide in elderly patients with asthma-chronic obstructive pulmonary disease overlap and other airway inflammatory diseases. Iran J Allergy Asthma Immunol. 2018;17:232–239.29908540
   PubMed Web of Science ®Google Scholar
• LiuX, ZhangH, WangY, et al. Fractional exhaled nitric oxide is associated with the severity of stable COPD. Copd. 2020;17(2):121–127. doi:10.1080/15412555.2019.170423132116037
   PubMedGoogle Scholar
• SinghD, KolsumU, BrightlingCE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.0016241425323230
   PubMed Web of Science ®Google Scholar
• YeM, LiQ, XiaoL, et al. Serum magnesium and fractional exhaled nitric oxide in relation to the severity in asthma-chronic obstructive pulmonary disease overlap. Biol Trace Elem Res. 2020. doi:10.1007/s12011-020-02314-5
   Web of Science ®Google Scholar
• BrindicciC, KharitonovSA, ItoM, et al. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(1):21–30. doi:10.1164/rccm.200904-0493OC19797159
   PubMed Web of Science ®Google Scholar
• KuwalA, JoshiV, DuttN, et al. A prospective study of bacteriological etiology in hospitalized acute exacerbation of COPD patients: relationship with lung function and respiratory failure. Turk Thorac J. 2018;19(1):19–27. doi:10.5152/TurkThoracJ.2017.1703529404182
   PubMed Web of Science ®Google Scholar
• TanriverdiH, OrnekT, ErboyF, et al. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr. 2015;127(19–20):756–763. doi:10.1007/s00508-014-0690-625586444
   PubMed Web of Science ®Google Scholar
• van de GeijnGM, DenkerS, Meuleman-van WaningV, et al. Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations. Int J Lab Hematol. 2016;38(6):616–628. doi:10.1111/ijlh.1255027459873
   PubMed Web of Science ®Google Scholar
• QureshiH, SharafkhanehA, HananiaNA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014;5(5):212–227. doi:10.1177/204062231453286225177479
   PubMedGoogle Scholar
• LowEV, HughesSM, ZaffarullahS, et al. ICS use may modify FEV1 decline in α1-antitrypsin deficiency patients with relatively high blood eosinophils. Respiration. 2018;95(2):114–121. doi:10.1159/00048186729253843
   PubMed Web of Science ®Google Scholar
• BlakeTL, ChangAB, ChatfieldMD, et al. Does ethnicity influence fractional exhaled nitric oxide in healthy individuals? A systematic review. Chest. 2017;152(1):40–50. doi:10.1016/j.chest.2017.02.00728215791
   PubMed Web of Science ®Google Scholar
• HuangT, LiuB, YangD, et al. Fractional exhaled nitric oxide measurement: comparison between the Sunvou-CA2122 analyzer and the NIOX VERO analyzer. J Asthma. 2019:1–8. doi:10.1080/02770903.2019.1658206.
   Web of Science ®Google Scholar
• HeL, LiZ, TengY, et al. Associations of personal exposure to air pollutants with airway mechanics in children with asthma. Environ Int. 2020;138:105647. doi:10.1016/j.envint.2020.10564732172043
   PubMed Web of Science ®Google Scholar
• YangX, XiaoH, WuQ, et al. Numerical study of air pollution over a typical basin topography: source appointment of fine particulate matter during one severe haze in the megacity Xi’an. Sci Total Environ. 2020;708:135213. doi:10.1016/j.scitotenv.2019.13521331812406
   PubMed Web of Science ®Google Scholar
• YuH, FengJ, SuX, et al. A seriously air pollution area affected by anthropogenic in the central China: temporal-spatial distribution and potential sources. Environ Geochem Health. 2020;42(10):3199–3211. doi:10.1007/s10653-020-00558-732306229
   PubMed Web of Science ®Google Scholar